HOME          ABOUT ERC          RESEARCHERS          FUNDERS         ELC               Log In with my.aesnet.org
ERC








Research
New Therapy Commercialization Grants Program
The purpose of the New Therapy - Commercialization Grants Program and Epilepsy Innovation Seal of Excellence Award is to drive the development of new therapies for epilepsy, accelerating the advancement of research from the laboratory to the patient.

The Program seeks to advance the development of new therapies including but not limited to medicines, biologics or devices. All proposals must demonstrate a clear path from the lab to the patient and are evaluated with consideration for their potential value to patients, likelihood of successful development including regulatory approval and the timeframe of development. The Program also encourages 1:1 matching grants to academic and commercial entities to support the commercialization of novel approaches to the treatment of epilepsy. Preference will be given to proposals that already have a commercial partner engaged to assist with development, and to proposals that have committed or matched funding from a sponsoring institution, commercial partner or other third party source.
Opportunity Contact:
grants administrator   
Dates LOI Dates

Open: 7/21/19
Close: 9/28/19
Response: 10/15/19
Dates Application Dates

Open: 10/15/19
Close: 1/7/20
Response: 3/15/20
Funding Level: $200,000
Funding Length: 24 months
Funding Start Date: 7/1/20
 
Please enter your email address below. If you are already a member you will be logged in. If you are not a current member, you will be registered automatically.



The email address you entered is associated with an existing account.